Mangoceuticals, Inc.
MGRX· Nasdaq
MGRXMangoceuticals, Inc.
Who holds Mangoceuticals, Inc., from the managers’ Form 13F reports for the quarter ended Jun 30, 2026.
Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.
| Manager | Shares | Change | Value | Of portfolio | Filed |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 339K | New | $128.8K | 0% | Sep 2, 2026 |
| XTX Topco Ltd | 186.3K | +1,317.3% | $70.8K | 0.1% | Aug 14, 2026 |
| Geode Capital Management, LLC | 156.2K | −19.7% | $59.4K | 0% | Aug 12, 2026 |
| Ikarian Capital, LLC | 138.1K | ±0% | $52.5K | 0.1% | Aug 14, 2026 |
| Vanguard Capital Management LLC | 123K | ±0% | $46.8K | 0% | Aug 13, 2026 |
| Vanguard Fiduciary Trust Co | 57.2K | ±0% | $21.7K | 0% | Aug 13, 2026 |
| Boothbay Fund Management, LLC | 38.4K | ±0% | $14.6K | 0.1% | Aug 14, 2026 |
| Northern Trust Corp | 37.6K | ±0% | $14.3K | 0% | Aug 13, 2026 |
| Ackerman Capital Advisors, LLC | 34.5K | ±0% | $13.1K | 0.1% | Jul 30, 2026 |
| ACT Advisors, LLC. | 26.9K | New | $10.2K | 0.1% | Jul 22, 2026 |
| Goldman Sachs Group Inc | 11.6K | −1.4% | $4.4K | 0% | Aug 14, 2026 |
| Csenge Advisory Group | 10K | ±0% | $3.8K | 0.1% | Aug 10, 2026 |
| Ameriflex Group, Inc. | 2.9K | New | $1.1K | 0.1% | Aug 14, 2026 |
| Fortitude Family Office, LLC | 1.3K | ±0% | $510 | 0.1% | Jul 20, 2026 |
| Morgan Stanley | 1K | ±0% | $380 | 0% | Aug 13, 2026 |
| Tower Research Capital LLC (TRC) | 783 | −0.3% | $298 | 0% | Aug 11, 2026 |
| HRT Financial LP | 36K | New | $13 | 0% | Aug 14, 2026 |
| Barclays PLC | 5 | New | $2 | 0% | Aug 14, 2026 |
